PUMA BIOTECHNOLOGY, INC.
Cash Flow Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $5.8M | $2.1M | $1.4M | $-360.0K | $9.4M | $-3.4M | $-44.7M | $-5.1M |
| Depreciation & Amortization | — | — | $2.9M | — | — | $2.5M | — | — |
| Depreciation | $100.0K | $100.0K | $100.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K |
| Amortization | $2.4M | $2.4M | $2.4M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M |
| Stock-Based Compensation | — | — | $2.8M | — | — | $3.1M | — | — |
| Net Cash from Operating Activities | $10.6M | $3.3M | $2.6M | $17.3M | $-13.9M | $-26.9M | $10.5M | $-74.0K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-17.5M | — | — | $9.0M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $0 | — | — | $9.8M | — | — |
| Net Change in Cash | — | — | $-14.8M | — | — | $-8.1M | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |